Identification of novel phosphoproteomic biomarkers in patients with advanced hepatocellular carcinoma (HCC)

被引：0
|
作者：
Sarker, Debashis
Pedicona, Federico
Zen, Yoh
Borek, Weronika E.
Khorsandi, Shirin Elizabeth
Christopher, Josie
Karampera, Christina
Dowe, Thomas
Heaton, Nigel
Cutillas, Pedro Rodriguez
Dokal, Arran David
Britton, David James
机构：
[1] Kings Coll London, London, England
[2] Kinom Ltd, Macclesfield, Cheshire, England
[3] Kings Coll Hosp London, London, England
[4] Kings Coll Hosp London, Inst Liver Studies, London, England
[5] Kings Coll Hosp London, London, England
[6] Queen Mary Univ London, Barts Canc Inst, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15155
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Frequency of Elevated Hepatocellular Carcinoma (HCC) Biomarkers in Patients With Advanced Hepatitis C
    Sterling, Richard K.
    Wright, Elizabeth C.
    Morgan, Timothy R.
    Seeff, Leonard B.
    Hoefs, John C.
    Di Bisceglie, Adrian M.
    Dienstag, Jules L.
    Lok, Anna S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (01): : 64 - 74
  • [2] Identification of clinical biomarkers for patients with advanced hepatocellular carcinoma receiving sorafenib
    A. Lamarca
    O. Abdel-Rahman
    I. Salu
    M. G. McNamara
    J. W. Valle
    R. A. Hubner
    Clinical and Translational Oncology, 2017, 19 : 364 - 372
  • [3] Identification of clinical biomarkers for patients with advanced hepatocellular carcinoma receiving sorafenib
    Lamarca, A.
    Abdel-Rahman, O.
    Salu, I.
    McNamara, M. G.
    Valle, J. W.
    Hubner, R. A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (03): : 364 - 372
  • [4] Biomarkers for Hepatocellular Carcinoma (HCC): An Update
    Li, Dave
    Satomura, Shinji
    ADVANCES IN CANCER BIOMARKERS: FROM BIOCHEMISTRY TO CLINIC FOR A CRITICAL REVISION, 2015, 867 : 179 - 193
  • [5] Novel antiangiogenic therapies against advanced hepatocellular carcinoma (HCC)
    Pazo-Cid, R. A.
    Lanzuela, M.
    Esquerdo, G.
    Perez-Gracia, J. L.
    Anton, A.
    Amigo, G.
    Martinez Trufero, J.
    Garcia-Otin, A. L.
    Martin-Duque, P.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (08): : 564 - 574
  • [6] Novel antiangiogenic therapies against advanced hepatocellular carcinoma (HCC)
    R. A. Pazo-Cid
    M. Lanzuela
    G. Esquerdo
    J. L. Pérez-Gracia
    A. Antón
    G. Amigo
    J. Martínez Trufero
    A. L. García-Otín
    P. Martín-Duque
    Clinical and Translational Oncology, 2012, 14 : 564 - 574
  • [7] Identification of a predictive phosphoproteomic signature of response to atezolizumab and bevacizumab (AB) in patients with advanced hepatocellular carcinoma (aHCC)
    Sarker, Debashis
    Borek, Weronika E.
    Pedicona, Federico
    Zen, Yoh
    Christopher, Josie A.
    Karampera, Christina
    Campbell, Amy
    Khorsandi, Shirin Elizabeth
    Dowe, Thomas
    Habarwaa, Marwo
    Britton, David James
    Heaton, Nigel
    Cutillas, Pedro Rodriguez
    Williamson, Andrew
    Dokal, Arran David
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Identification of novel blood-based HCC-specific diagnostic biomarkers for human hepatocellular carcinoma
    Yin, Li
    He, Na
    Chen, Chuizhe
    Zhang, Nan
    Lin, Yingzi
    Xia, Qianfeng
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 47 (01) : 1908 - 1916
  • [9] Identification of potentially actionable molecular alterations in advanced hepatocellular carcinoma (HCC).
    Harding, James J.
    Heins, Zachary J.
    Connell, Louise Catherine
    Soumerai, Tara
    Kemeny, Nancy E.
    Jarnagin, William R.
    O'Reilly, Eileen Mary
    DeMatteo, Ronald P.
    D'Angelica, Michael Ian
    Lowery, Maeve Aine
    Kingham, T. Peter
    Gambarin, Maya
    Hyman, David Michael
    Ly, Michele
    Hamilton, Casey R.
    Berger, Michael F.
    Solit, David B.
    Saltz, Leonard
    Schultz, Nikolaus
    Abou-Alfa, Ghassan K.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] Evaluation of patupilone as monotherapy in patients with advanced hepatocellular carcinoma (HCC)
    Venook, A. P.
    Poon, R.
    Kang, Y. K.
    Mok, T. S.
    Chao, Y.
    de Bedout, S.
    Harbott, A.
    Li, J.
    Johri, A. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345